These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 17451368)

  • 1. Cnot7-null mice exhibit high bone mass phenotype and modulation of BMP actions.
    Washio-Oikawa K; Nakamura T; Usui M; Yoneda M; Ezura Y; Ishikawa I; Nakashima K; Noda T; Yamamoto T; Noda M
    J Bone Miner Res; 2007 Aug; 22(8):1217-23. PubMed ID: 17451368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation.
    Morinobu M; Nakamoto T; Hino K; Tsuji K; Shen ZJ; Nakashima K; Nifuji A; Yamamoto H; Hirai H; Noda M
    J Exp Med; 2005 Mar; 201(6):961-70. PubMed ID: 15781586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
    Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
    Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression analysis of LacZ gene placed in the locus of Cnot7 exhibits its activity in osteoblasts in vivo and in mineralized nodules in vitro.
    Washio-Oikawa K; Nakamura T; Usui M; Yoneda M; Ezura Y; Ishikawa I; Nakashima K; Yamamoto T; Noda M
    J Cell Biochem; 2006 Oct; 99(2):538-44. PubMed ID: 16639713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type and Nf1 haploinsufficient mice.
    Schindeler A; Ramachandran M; Godfrey C; Morse A; McDonald M; Mikulec K; Little DG
    J Orthop Res; 2008 Jan; 26(1):65-74. PubMed ID: 17787010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twisted gastrulation, a bone morphogenetic protein agonist/antagonist, is not required for post-natal skeletal function.
    Gazzerro E; Deregowski V; Stadmeyer L; Gale NW; Economides AN; Canalis E
    Bone; 2006 Dec; 39(6):1252-60. PubMed ID: 16934545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model.
    Zhu W; Rawlins BA; Boachie-Adjei O; Myers ER; Arimizu J; Choi E; Lieberman JR; Crystal RG; Hidaka C
    J Bone Miner Res; 2004 Dec; 19(12):2021-32. PubMed ID: 15537446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic protein regulation of forkhead/winged helix transcription factor Foxc2 (Mfh1) in a murine mesodermal cell line C1 and in skeletal precursor cells.
    Nifuji A; Miura N; Kato N; Kellermann O; Noda M
    J Bone Miner Res; 2001 Oct; 16(10):1765-71. PubMed ID: 11585339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory helix-loop-helix transcription factors Id1/Id3 promote bone formation in vivo.
    Maeda Y; Tsuji K; Nifuji A; Noda M
    J Cell Biochem; 2004 Oct; 93(2):337-44. PubMed ID: 15368360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
    Okamoto M; Murai J; Yoshikawa H; Tsumaki N
    J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous TNFalpha lowers maximum peak bone mass and inhibits osteoblastic Smad activation through NF-kappaB.
    Li Y; Li A; Strait K; Zhang H; Nanes MS; Weitzmann MN
    J Bone Miner Res; 2007 May; 22(5):646-55. PubMed ID: 17266397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
    Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
    J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
    Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
    Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass.
    Morvan F; Boulukos K; Clément-Lacroix P; Roman Roman S; Suc-Royer I; Vayssière B; Ammann P; Martin P; Pinho S; Pognonec P; Mollat P; Niehrs C; Baron R; Rawadi G
    J Bone Miner Res; 2006 Jun; 21(6):934-45. PubMed ID: 16753024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein-2 facilitates expression of chondrogenic, not osteogenic, phenotype of human intervertebral disc cells.
    Kim DJ; Moon SH; Kim H; Kwon UH; Park MS; Han KJ; Hahn SB; Lee HM
    Spine (Phila Pa 1976); 2003 Dec; 28(24):2679-84. PubMed ID: 14673369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired growth plate function in bmp-6 null mice.
    Perry MJ; McDougall KE; Hou SC; Tobias JH
    Bone; 2008 Jan; 42(1):216-25. PubMed ID: 17980691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
    Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
    J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Full-length bovine spp24 [spp24 (24-203)] inhibits BMP-2 induced bone formation.
    Sintuu C; Murray SS; Behnam K; Simon R; Jawien J; Silva JD; Duarte ME; Brochmann EJ
    J Orthop Res; 2008 Jun; 26(6):753-8. PubMed ID: 18253966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo.
    Chikazu D; Li X; Kawaguchi H; Sakuma Y; Voznesensky OS; Adams DJ; Xu M; Hoshio K; Katavic V; Herschman HR; Raisz LG; Pilbeam CC
    J Bone Miner Res; 2002 Aug; 17(8):1430-40. PubMed ID: 12162497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.